Kura Oncology, Inc. (KURA)
10.66
+0.14
(+1.28%)
USD |
NASDAQ |
Oct 07, 16:00
10.70
+0.04
(+0.33%)
After-Hours: 20:00
Kura Oncology Price : 10.66 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 10.75 | 10.88 | 10.34 | 10.53 | 1.310M |
| Oct 05, 2026 | 10.73 | 10.80 | 10.29 | 10.62 | 1.295M |
| Oct 02, 2026 | 10.85 | 10.97 | 10.59 | 10.65 | 1.887M |
| Oct 01, 2026 | 11.10 | 11.12 | 10.59 | 10.65 | 2.431M |
| Sep 30, 2026 | 10.90 | 10.95 | 10.60 | 10.71 | 1.871M |
| Sep 29, 2026 | 10.65 | 10.90 | 10.54 | 10.80 | 1.890M |
| Sep 28, 2026 | 10.71 | 10.83 | 10.36 | 10.61 | 1.646M |
| Sep 25, 2026 | 10.88 | 10.96 | 10.75 | 10.76 | 1.227M |
| Sep 24, 2026 | 11.00 | 11.08 | 10.66 | 10.86 | 1.772M |
| Sep 23, 2026 | 11.73 | 11.81 | 10.82 | 11.04 | 2.772M |
| Sep 22, 2026 | 11.80 | 11.98 | 11.58 | 11.73 | 1.681M |
| Sep 21, 2026 | 11.86 | 12.00 | 11.49 | 11.60 | 1.763M |
| Sep 18, 2026 | 11.64 | 11.84 | 11.56 | 11.73 | 2.665M |
| Sep 17, 2026 | 11.39 | 12.20 | 11.35 | 11.72 | 1.852M |
| Sep 16, 2026 | 11.31 | 11.52 | 11.14 | 11.20 | 1.793M |
| Sep 15, 2026 | 11.48 | 11.48 | 11.02 | 11.30 | 1.827M |
| Sep 14, 2026 | 11.37 | 11.68 | 11.25 | 11.56 | 1.458M |
| Sep 11, 2026 | 11.58 | 11.75 | 11.34 | 11.39 | 2.118M |
| Sep 10, 2026 | 12.00 | 12.00 | 11.44 | 11.57 | 1.814M |
| Sep 09, 2026 | 12.50 | 12.61 | 11.99 | 12.09 | 2.213M |
| Sep 08, 2026 | 12.92 | 12.92 | 12.50 | 12.52 | 1.512M |
| Sep 04, 2026 | 12.94 | 13.27 | 12.89 | 13.25 | 1.314M |
| Sep 03, 2026 | 13.25 | 13.29 | 12.85 | 13.15 | 1.478M |
| Sep 02, 2026 | 12.89 | 13.41 | 12.66 | 13.11 | 1.885M |
| Sep 01, 2026 | 12.54 | 12.96 | 12.43 | 12.89 | 1.513M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.15 |
| Fortress Biotech, Inc. | 2.06 |
| Spero Therapeutics, Inc. | 1.165 |
| Gossamer Bio, Inc. | 10.11 |
| ACADIA Pharmaceuticals, Inc. | 19.64 |
Price Related Metrics
| PS Ratio | 12.19 |
| PEG Ratio | -0.0649 |
| Price to Book Value | 19.59 |
| Earnings Yield | -31.52% |
| Market Cap | 948.69M |
| PEGY Ratio | -0.0649 |